Eradication of minimal residual disease in chronic lymphocytic leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2008, v. 3, n. 1, p. 54, doi. 10.1007/s11899-008-0009-7
- By:
- Publication type:
- Article
Works matching IS 15588211 AND DT 2008 AND VI 3 AND IP 1
Results: 9
1
2
Assessing minimal residual disease in chronic lymphocytic leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2008, v. 3, n. 1, p. 47, doi. 10.1007/s11899-008-0008-8
- By:
- Publication type:
- Article
3
Primary eosinophilic disorders: A concise review.
- Published in:
- Current Hematologic Malignancy Reports, 2008, v. 3, n. 1, p. 37, doi. 10.1007/s11899-008-0007-9
- By:
- Publication type:
- Article
4
Diagnosis and management of chronic myelomonocytic leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2008, v. 3, n. 1, p. 31, doi. 10.1007/s11899-008-0006-x
- By:
- Publication type:
- Article
5
Immunosuppressive therapy for myelodysplastic syndromes: Refining the indications.
- Published in:
- Current Hematologic Malignancy Reports, 2008, v. 3, n. 1, p. 23, doi. 10.1007/s11899-008-0005-y
- By:
- Publication type:
- Article
6
Prognosis in myelodysplastic syndromes: Are the new classifications useful?
- Published in:
- Current Hematologic Malignancy Reports, 2008, v. 3, n. 1, p. 19, doi. 10.1007/s11899-008-0004-z
- By:
- Publication type:
- Article
7
Antiangiogenic therapy in myelodysplastic syndromes: Is there a role?
- Published in:
- Current Hematologic Malignancy Reports, 2008, v. 3, n. 1, p. 10, doi. 10.1007/s11899-008-0003-0
- By:
- Publication type:
- Article
8
Lenalidomide in myelodysplastic syndromes: Where do we go from here?
- Published in:
- Current Hematologic Malignancy Reports, 2008, v. 3, n. 1, p. 5, doi. 10.1007/s11899-008-0002-1
- By:
- Publication type:
- Article
9
Web alert.
- Published in:
- Current Hematologic Malignancy Reports, 2008, v. 3, n. 1, p. 1, doi. 10.1007/s11899-008-0001-2
- Publication type:
- Article